KDx Diagnostics And Lister Hospital Announce The Launch Of A Non-Invasive URO17® Urine Test For Bladder Cancer In The United Kingdom
SAN JOSE, Calif. and STEVENAGE, England, Dec. 5, 2021 /PRNewswire/ -- KDx Diagnostics, Inc. , and Lister Hospital , Stevenage, UK, announced today the launch in the United Kingdom of KDx's...
Source: marketscreener.com